Insights into the association of ACEIs/ARBs use and COVID-19 prognosis: a multistate modelling study of nationwide hospital surveillance data from Belgium

OBJECTIVES: The widespread use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) by patients with chronic conditions raised early concerns on the potential exacerbation of COVID-19 severity and fatality. Previous studies addressing this question have used s...

Descripción completa

Detalles Bibliográficos
Autores principales: Peñalvo, José L., Genbrugge, Els, Mertens, Elly, Sagastume, Diana, van der Sande, Marianne A B, Widdowson, Marc-Alain, Van Beckhoven, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449849/
https://www.ncbi.nlm.nih.gov/pubmed/34531225
http://dx.doi.org/10.1136/bmjopen-2021-053393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449849/
https://www.ncbi.nlm.nih.gov/pubmed/34531225
http://dx.doi.org/10.1136/bmjopen-2021-053393

Ejemplares similares